Skip to main content

Advertisement

Log in

Clinical and epidemiological characteristics of patients with influenza A (H1N1) 2009 attended to at the emergency room of a children's hospital

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

In June 2009, the first influenza pandemic of the twenty-first century, due to the swine origin influenza A (H1N1) 2009 virus, was declared. This study aimed to describe the epidemiological and clinical features, complications, lethality and risk factors for hospital admission of microbiologically confirmed cases of influenza A (H1N1) 2009 infection seen at the emergency department of a children’s hospital. All cases of children with influenza A (H1N1) 2009 viral infection, confirmed microbiologically by real-time reverse transcription polymerase chain reactions and treated in the emergency room between July and December 2009, were prospectively included. Patients were compared according to admission requirement to study variables associated with the risk of hospitalisation. Oseltamivir was the antiviral used for the treatment and its safety was analysed. Four hundred and twelve patients with influenza A (H1N1) 2009 infection were included. The most frequent symptoms were: fever (96%), cough (95%) and coryza (90%). Eighty-five patients (20.6%) were admitted: three to the paediatric intensive care unit and two died. Hospitalised children were younger than those not admitted (median age 5 vs 8 years; p = 0.001). Age under 1 year (OR 6.01; CI 95% 2.77–13.05), pneumonia (OR 7.99; CI 95% 3.50–18.22) and haemoglobinopathy or underlying blood disorders (OR 5.99; CI 95% 1.32–27.30) were statistically significant risk factors for admission. No differences were observed regarding onset of antiviral treatment among admitted and non-admitted patients. Treatment with oseltamivir was well tolerated. In conclusion, the incidence of severe cases and lethality of influenza A (H1N1) 2009 infection were low in our setting, even in a population with risk factors for developing complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Agencia Española de Medicamentos y Productos Sanitarios (2009) Recomendaciones para la preparación y administración de oseltamivir en niños menores de 1 año. Available at: http://www.aemps.es/actividad/documentos/notasPrensa/notaOseltamivir-Zanamivir_2.htm

  2. Asociación Española de Pediatría (2009) Informe técnico en pediatría sobre la gripe pandémica A (H1N1) 2009 Tratamiento con medicamentos antivirales Available at: http://www.aeped.es/documentos/informe-tecnico-en-pediatria-sobre-gripe-pandemica-h1n1. Accessed 21 Sept 2009

  3. Bryant PA, Tebruegge M, Papadakis G et al (2010) Clinical and microbiologic features associated with novel swine-origin influenza a pandemic 2009 (H1N1) Virus in children: a prospective cohort study. Pediatr Infect Dis J 29:694–698

    Article  PubMed  Google Scholar 

  4. CDC (2009) H1N1 flu: patient management. Available at: http://www.cdc.gov/h1n1flu/clinicians/patient_management/. Accessed 24 Sep 2009

  5. CDC (2009) H1N1 flu. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. Available at: http://www.cdc.gov/h1n1flu/recommendations.htm. Accessed 24 Sep 2009

  6. CDC (2009) Outbreak of swine-origin Influenza A (H1N1) virus infection—Mexico, March–April 2009. MMWR Morb Mortal Wkly Rep 58:467–470

    Google Scholar 

  7. CDC (2009) CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April–November 14, 2009. Available at: http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm. Accessed 17 Dec 2009

  8. Cox NJ, Subbarao K (1999) Influenza. Lancet 354:1277–1282

    Article  PubMed  CAS  Google Scholar 

  9. Dawood SK, Jain S, Finelli L et al (2009) Novel swine-origin influenza A (H1N1) virus investigation team. Emergence of novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360:2605–2615

    Article  PubMed  Google Scholar 

  10. Departament de Salut, Generalitat de Catalunya (2009) El departament de Salut fa balanç de la pandèmia de grip A (H1N1) a Catalunya. Available at: http://www.gencat.cat/salut/depsalut/html/ca/premsa/doc33532.html

  11. Departament de Salut, Generalitat de Catalunya (2009) La pandèmia en xifres. Context i resposta a Catalunya. Available at: http://www.gencat.cat/salut/depsalut/html/ca/premsa/plasencia.pdf

  12. Departament de Salut, Generalitat de Catalunya (2009) Pla d’actuació a Catalunya enfront d’una infecció pel virus pandèmic (H1N1) 2009. Available at: http://www.gencat.cat/salut/depsalut/html/ca/dir3341/gr27042009.pdf

  13. European Medicines Agency (2009) European Public Assessment Report for Tamiflu. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000402/WC500033101.pdf

  14. Food and Drug Administration (2009) Emergency use of Tamiflu in infants less than one year of age. Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm183870.htm. Accessed 18 Nov 2009

  15. Garten RJ, Davis CT, Russell CA et al (2009) Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 325:197–201

    Article  PubMed  CAS  Google Scholar 

  16. Health Protection Agency (2009) Pandemic (H1N1) 2009 in England: an overview of initial epidemiological findings and implications for the second wave. v3 24. Available at: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1258560552857. Accessed 18 Dec 2009

  17. Jain R, Goldman RD (2009) Novel influenza A (H1N1) clinical presentation, diagnosis and management. Pediatr Emerg Care 25:791–796

    Article  PubMed  Google Scholar 

  18. Jain S, Kamimoto L, Bramley AM et al (2009) Hospitalized patients with 2009 H1N1 Influenza in the United States, April–June 2009. N Engl J Med 361:1935–1944

    Article  PubMed  CAS  Google Scholar 

  19. Kitching A, Roche A, Balasegaram S et al (2009) Oseltamivir adherence and side effects among children in three London schools affected by influenza A (H1N1)v, May 2009—an internet-based cross-sectorial survey. Euro surveill. Available at: http:// www.eurosurveillance.org/images/dynamic/EE/V14N30/art 19287.pdf. Accessed 25 August 2009

  20. Kumar S, Havens PL, Chusid MJ et al (2010) Clinical and epidemiological characteristics of children hospitalized with 2009 pandemic H1N1 influenza A infection. Pediatr Infect Dis J 29:591–594

    Article  PubMed  Google Scholar 

  21. Libster R, Bugna J, Coviello S et al (2010) Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 362:45–55

    Article  PubMed  CAS  Google Scholar 

  22. Ministerio de Sanidad y Política Social (2009) Comunicado sobre el brote humano de gripe de origen porcino. Available at: http://www.msps.es/servCiudadanos/alertas/gripeAH1N1.htm

  23. Moore DL, Vaudry W, Scheifele DW et al (2006) Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003–2004. Pediatrics 118:e610–e619

    Article  PubMed  Google Scholar 

  24. Nicholson KG (1992) Clinical features of influenza. Semin Respir Infect 7:26–37

    PubMed  CAS  Google Scholar 

  25. Shun-Shin M, Thompson M, Heneghan C et al (2009) Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomized controlled trials. BMJ 339:b3172

    Article  PubMed  Google Scholar 

  26. Suwannakarn K, Payungporn S, Chieochansin T et al (2008) Typing (A/B) and subtyping (H1/H3/H5) of influenza A viruses by multiplex real-time RT-PCR assays. J Virol Methods 152:25–31

    Article  PubMed  CAS  Google Scholar 

  27. Torres JP, O’Ryan M, Herve B et al (2010) Impact of the novel influenza A (H1N1) during the 2009 autumn–winter season in a large hospital setting in Santiago, Chile. Clin Infect Dis 50:860–868

    Article  PubMed  Google Scholar 

  28. U.S Department of Health and Human Services (2009) Assessment of the Influenza A (H1N1) pandemic on selected countries in the southern hemisphere: Argentina, Australia, Chile, New Zealand and Uruguay. Available at: http://www.flu.gov/professional/global/southhemilphere.html. Accessed 11 Nov 2009

  29. Wallensten A, Oliver I, Lewis D el al (2009) Compliance and side effects of prophylactic oseltamivir treatment in a school of south-west England. Euro surveill. Available at: http://www.eurosurveillance.org/images/dynamic/EE/V14N30/art19285.pdf. Accessed 25 Aug 2009

  30. World Health Organization (2009) Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. Available at: http://www.who.int/csr/resources/publications/swineflu/clinical_managementh1n1.pdf

  31. World Health Organization (2009) Statement to the press by World Health Organization Director-General. Available at: http://www.who.int/mediacentre/news/. Accessed 13 Aug 2009

  32. Yorifuji T, Suzuki E, Tsudab T (2009) Oseltamivir and abnormal behaviors. True or not? Epidemiology 20:619–621

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Esther Lera.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lera, E., T.Wörner, N., Sancosmed, M. et al. Clinical and epidemiological characteristics of patients with influenza A (H1N1) 2009 attended to at the emergency room of a children's hospital. Eur J Pediatr 170, 371–378 (2011). https://doi.org/10.1007/s00431-011-1399-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-011-1399-4

Keywords

Navigation